Skip to main content

Protective role of epigallocatechin 3-gallate against lead-induced toxicity in human neuroblastoma cells

Buy Article:

$71.00 + tax (Refund Policy)

Lead (Pb) is a heavy metal, known to induce oxidative stress and produce damage to the antioxidant defence system ultimately leading to cell death. Antioxidants such as epigallocatechin 3-gallate (EGCG), a green tea polyphenol, was shown to play a protective role during Pb-exposure. In this study, human SH-SY5Y neuroblastoma cells were exposed to different concentrations (0.01-10 µM) of Pb for 48 h to determine effects on the viability of cells. It was observed that IC50 was at 5 µM and at this concentration the cells exhibited a significant increase in caspase-3 activity, an indicator of apoptosis at least by 10-fold and the decrease of 59.4% in glutathione (GSH) content. The total cellular prostaglandin-E2 (PGE2) level was found to be elevated at least 10-fold upon Pb exposure. However, the effects of Pb on cells pre-incubated with 50 µM EGCG followed by 5 µM Pb showed 40% inhibition in cell viability, 17.3% decrease in caspase-3 activity, 23% increase in GSH content, and 11.4% fall in PGE2 levels when compared with cells exposed to Pb only. Data suggest that EGCG exerted a significant protection to cell viability in preventing cell death and elevation in levels of GSH in cells exposed to Pb. However, EGCG did not elicit any significant effect on release of PGE2 indicating the nature of EGCG as an effective anti-apoptotic, antioxidant, and anti-inflammatory agent.

Keywords: caspase-3; epigallocatechin 3-gallate; glutathione; lead; neuroblastoma cells; prostaglandin E2

Document Type: Research Article

Affiliations: 1: Department of Biochemistry, National Institute of Nutrition, Hyderabad-500007, AP, India 2: Department of Natural Sciences, Savannah State University, Savannah, GA 31404, USA

Publication date: 01 May 2011

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content